17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer-Reference-Cited by-同舟云学术

17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer

Published:2008-01-08 Issue:9 Volume:122 Page:1931-1940
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Day Joanna M.,Foster Paul A.,Tutill Helena J.,Parsons Michael F.C.,Newman Simon P.,Chander Surinder K.,Allan Gillian M.,Lawrence Harshani R.,Vicker Nigel,Potter Barry V.L.,Reed Michael J.,Purohit Atul

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Structure and function of human 17β-hydroxysteroid dehydrogenases;Lukacik;Mol Cell Endocrinol,2006

2. Multifunctionality of human 17β-hydroxysteroid dehydrogenases;Moeller;Mol Cell Endocrinol,2006

3. Regulation of estradiol 17β-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells;Reed;Endocrinology,1994

4. Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition;Luu-The;J Steroid Biochem Mol Biol,1995

5. Transcriptional regulation of human and murine 17β-hydroxysteroid dehydrogenase type-7 confers its participation in cholesterol biosynthesis;Ohnesorg;J Mol Endocrinol,2006

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of genes related to sexual differentiation and sterility in embryonic gonads of Mule ducks by transcriptome analysis;Frontiers in Genetics;2022-10-26

2. Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice;International Journal of Molecular Sciences;2022-04-27

3. Anticancer potential of β-sitosterol and oleanolic acid as through inhibition of human estrogenic 17beta-hydroxysteroid dehydrogenase type-1 based on an in silico approach;RSC Advances;2022

4. A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models;Cancers;2021-04-13

5. N ‐Phenyl‐1,2,3,4‐tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β‐Hydroxysteroid Dehydrogenase 1 Inhibitors;ChemMedChem;2020-11-25